MegatrendsMegatrends: not the usual suspects, but who actually profits.View megatrends →

Metrics as of 10/13/2026, 06:34 PM (Berlin time), refresh in progress.

Pfizer Stock

Pfizer Inc.

PFE.TOTSXMarkt
CA$13.15
+0.5% today

Company data

Sector
Healthcare
Industry
Drug Manufacturers - General
Country
United States
CEO
Albert Bourla
Employees
75,000
Market cap
$75 B
IPO
22/12/2025

Pfizer Inc. is a research-based global biopharmaceutical company headquartered in New York City, USA. The firm engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. Operating across both developed and emerging markets, the company works to…

Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.

Pfizer stock: price history

22/12/25+15.1 %16/10/26

1D

+0.5%

1W

+4.6%

1M

+7.7%

6M

+6.1%

YTD

+16.7%

1Y

–

2Y

–

5Y

–

10Y

–

Ask the agents about Pfizer

Free float & liquidity

FREE FLOAT

–

FLOAT SHARES

–

AVG. DAILY VOLUME (30D)

103,199

Dividends

EX-DATEPAY DATEAMOUNTYIELD
06/11/202614/12/2026CA$0.196.1 %
24/07/202609/09/2026CA$0.197 %
08/05/202619/06/2026CA$0.196.7 %
23/01/202613/03/2026CA$0.196.7 %
07/11/2025–CA$0.196.8 %
Page 1 / 4

Comparable stocks

Frequently asked questions about Pfizer stock

What does Pfizer do?

Pfizer Inc. is a company in the Healthcare sector, Drug Manufacturers - General industry, headquartered in United States.

The CEO is Albert Bourla, the company employs around 75,000 people.

The IPO was on 22/12/2025; the stock trades on TSX under the ticker PFE.TO.

Does Pfizer pay a dividend?

Yes. The last dividend was CA$0.19 per share, ex-date 06/11/2026, paid on 14/12/2026.

Which stocks are comparable to Pfizer?

Comparable stocks include Eli Lilly and Company, Johnson & Johnson, AbbVie, Merck &, Amgen, Gilead Sciences, Pfizer and Bristol-Myers Squibb Company.

How can I get Pfizer stock analyzed?

Clicking "Analyze stock" lets five strategies assess Pfizer against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.

Not investment advice. Past performance is not an indicator of future results.